n CME : Your SA Journal of CPD - Advances in hepatitis B : more about... gastroenterology




Hepatitis B virus (HBV) remains an important public health issue in South Africa. Prior to the incorporation of HBV vaccination into the Expanded Programme of Immunisation (EPI) more than a decade ago, prevalence rates of HBV were estimated at between 0.3% and 15%. However, the potential benefits of introducing the vaccine have not yet been accurately assessed and may not be fully realised without complete vaccination coverage. A further potentially negative factor in HBV control is the burgeoning HIV / AIDS epidemic as the natural history of HBV is altered in those who are co-infected. The long-term risks of chronic HBV infection include chronic hepatitis, which may evolve to cirrhosis and the risk of hepatocellular carcinoma is significantly increased, irrespective of the presence of cirrhosis.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error